According to Lakewood-Amedex Biotherapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ5.66. In 2025 the company made an earnings per share (EPS) of -ยฃ2.05 an increase over its 2024 EPS that were of -ยฃ5.15.